In the last trading session, 2.1 million shares of the Checkpoint Therapeutics Inc (NASDAQ:CKPT) were traded, and its beta was 1.31. Most recently the company’s share price was $3.84, and it changed around $0.16 or 4.35% from the last close, which brings the market valuation of the company to $172.88M. CKPT currently trades at a discount to its 52-week high of $3.80, offering almost 1.04% off that amount. The share price’s 52-week low was $1.36, which indicates that the current value has risen by an impressive 64.58% since then. We note from Checkpoint Therapeutics Inc’s average daily trading volume that its 10-day average is 1.44 million shares, with the 3-month average coming to 507.91K.
Checkpoint Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended CKPT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Checkpoint Therapeutics Inc is expected to report earnings per share of -0.15 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information
Instantly CKPT has showed a green trend with a performance of 4.35% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.95 on recent trading dayincreased the stock’s daily price by 2.78%. The company’s shares are currently up 67.69% year-to-date, but still up 21.52% over the last five days. On the other hand, Checkpoint Therapeutics Inc (NASDAQ:CKPT) is 71.43% up in the 30-day period. We can see from the shorts that 4.61 million shares have been sold at a short interest cover period of 10.39 day(s).
Checkpoint Therapeutics Inc (CKPT) estimates and forecasts
Checkpoint Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 176.26 percent over the past six months and at a 74.45% annual growth rate that is well above the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 48.30% in revenue this quarter, and will report an increase of 85.50% in the next quarter. The year-over-year growth rate is expected to be -70.90%, down from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 10k in revenue for the current quarter. 3 analysts expect Checkpoint Therapeutics Inc to make 10k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 31k and 6k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -67.70%. Forecasts for the next quarter put sales growth at 66.70%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 26.32%.
CKPT Dividends
Checkpoint Therapeutics Inc’s next quarterly earnings report is expected to be released in November.
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 15.52% of Checkpoint Therapeutics Inc shares, and 13.68% of them are in the hands of institutional investors. The stock currently has a share float of 16.19%.
